Düsseldorf - At the MEDICA Tech Forum on Tuesday, November 14th, the focus will be on per- and polyfluorinated alkyl substances: a top-class group of representatives from industry, authorities and research will discuss the status of the restriction procedure at 3:15 p.m. in Hall 9 about how things can and should proceed from different perspectives – quo vadis, PFAS?
One focus of MEDICA in Düsseldorf is medical technology devices and products. This includes a whole range of systems and instruments for which one topic has become dominant in recent months: Do they contain PFAS? The EU-wide restriction proposal for “per- and polyfluorinated alkyl substances” is making waves and will be echoed on Tuesday, November 14th at 3:15 p.m. at the MEDICA Tech Forum, which is organized by MedicalMountains GmbH, ZVEI and the industry association SPECTARIS .
The panel discussion in Hall 9, Stand D10 under the title “PFAS – obstacle to innovation or driver of innovation” reflects the various aspects associated with the restriction procedure – background, process, effects. We're on the podium
- Dr. Carl Albrecht Danneberg (Federal Institute for Occupational Safety and Health),
- Yvonne Glienke (MedicalMountains GmbH),
- Dr. Martin Leonhard (KARL STORZ SE & Co. KG/SPECTARIS) and
- Dr. Stefan Löbbecke (Fraunhofer Institute for Chemical Technology ICT).
A keynote speech by Meinrad Kempf (MedicalMountains GmbH) paves the way for the following discussion, moderated by Tobias Wobbe.
The MEDICA Tech Forum offers a diverse range of lectures on all days of the trade fair, from Monday to Thursday. They are mainly held in English. An overview can be found under this link. At the same location, in Hall 9, D10, MedicalMountains GmbH can also be found at the joint stand with SPECTARIS.
- Compact information:
Panel discussion “PFAS – obstacle to innovation or driver of innovation”
Tuesday, November 14th,
3:15 p.m., MEDICA Tech Forum (Hall 9/D10)
